Yeast Produces Target for Dermatitis, Eczema and Skin Cancer Treatment

November 18, 2015

To improve the understanding of the human skin microbiome, the first comprehensive genomic and biologic study of all 14 species of malassezia—one of the top skin disease-causing microbes—was completed by an international team of scientists, led by researchers from A*STAR’s Genome Institute of Singapore, Institute of Medical Biology (IMB), Bioinfor­matics Institute and P&G.
Defining Malassezia
Malassezia is a type of yeast, which is found on the skin of all birds and warm blooded mammals, including humans. Although it forms naturally, Malassezia sometimes causes diseases such as:
Seborrheic dermatitis;
Eczema;
Dandruff; and
Skin cancer.
The breakthrough study identified multiple potential targets for treating these diseases, which can be caused by various species of malassezia.
Two species of malassezia—M. restricta and M. globosa—are present on all human scalps and are responsible for common dandruff and seborrheic dermatitis.
Read more at Skin Inc.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical
    • Botox Cosmetic’s “The Confidence Collective” to Empower 250 Women Entrepreneurs
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement